AMAG Pharmaceuticals Inc Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia Call
Llamada en conferencia AMAG Pharmaceuticals Inc
AMAG Pharmaceuticals Inc Conference call or earnings call will be held on 26-sep-2018 via an 800 number (toll-free). During the earnings conference call's session AMAG Pharmaceuticals Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact AMAG Pharmaceuticals Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
Founded in November 1981, Advanced Magnetics, Inc., or the Company, a Delaware corporation, is a biopharmaceutical company engaged in the development and commercialization of therapeutic iron compounds to treat anemia, as well as novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. We have two approved products, Feridex I.V.(R) and GastroMARK(R), and we have two product candidates, ferumoxytol and Combidex(R). Ferumoxytol, the Company's key product candidate, is being developed for use as an intravenous, or IV, iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease. Combidex is our investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging, or MRI, to aid in the differentiation of cancerous from normal lymph nodes.Leer más Llamada en conferencia